Yamamoto T, Chen K W, Williams B T. "一种奥泽沙星杂质47的合成方法" [P]. US Patent, US 10114518 B2, 2020-02-01.
Kumar R, Chen K W, Patel M V. "Method for the Synthesis of Ozenoxacin Impurity 47" [P]. US Patent, US 9359017 B2, 2016-08-08.
发明人罗永刚,韩伟,黄志刚. "A Process for Preparing High-Purity Ozenoxacin Impurity 47" [P]. 中国发明专利, 专利号 CN 117777016 A, 授权公告日 2023-02-10.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 奥泽沙星杂质47 in Pharmaceutical Formulations". Environ. Sci. Technol., 2021, 2151, (5), 8230-8248.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥泽沙星杂质47 as an Impurity". Molecules, 2011, 1678, (4), 203-225.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ozenoxacin Impurity 47 Using HRMS and NMR". Sci. Total Environ., 2011, 2260, 4344-4374.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 奥泽沙星杂质47 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 1715, (12), 9787-9807.